| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/1995 | EP0670314A1 Farnesyltransferase inhibitor |
| 09/06/1995 | EP0670300A2 Process for the preparation of allyl quinone derivatives, and intermediates |
| 09/06/1995 | EP0670167A1 Receptor mediated endocytosis type diagnostic agents |
| 09/06/1995 | EP0670164A1 Homeopathic solutions containing a nucleic acid |
| 09/06/1995 | EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases |
| 09/06/1995 | EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent |
| 09/06/1995 | EP0670161A1 Pharmaceutical compositions containing sodium cromoglycate and a bicyclic aromatic flavour |
| 09/06/1995 | EP0670157A1 Emulsion containing stabilised ascorbic acid |
| 09/06/1995 | EP0670047A1 Functional radar warning receiver back-up generator |
| 09/06/1995 | EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 09/06/1995 | EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 09/06/1995 | EP0669976A1 Transcription factor dp-1 |
| 09/06/1995 | EP0669942A1 Artificial antibodies, method of producing the same and use thereof |
| 09/06/1995 | EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 09/06/1995 | EP0669932A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase |
| 09/06/1995 | EP0669931A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 09/06/1995 | EP0669927A1 Sequence-specific binding polymers for duplex nucleic acids |
| 09/06/1995 | EP0669925A1 Aids therapeutics based on hiv ma peptides |
| 09/06/1995 | EP0669920A1 Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| 09/06/1995 | EP0669919A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 09/06/1995 | EP0669918A1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| 09/06/1995 | EP0669916A1 Novel method for preparing taxane derivatives, novel derivatives thus obtained and compositions containing them. |
| 09/06/1995 | EP0669914A1 Novel isoxazolines as antiinflammatory agents |
| 09/06/1995 | EP0669912A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 09/06/1995 | EP0669909A1 Substituted amidino compounds, their manufacture and methods of treatment |
| 09/06/1995 | EP0669835A1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols |
| 09/06/1995 | EP0669830A1 Substituted dipeptide analogs promote release of growth hormone |
| 09/06/1995 | EP0669827A1 Compositions for the regulation of cytokine activity |
| 09/06/1995 | EP0669826A1 Drug containing (-)-metriphonate |
| 09/06/1995 | EP0669825A1 Hydroxyl-containing compounds |
| 09/06/1995 | EP0669824A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 09/06/1995 | EP0669809A1 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 09/06/1995 | EP0656782A4 Nutritional product for persons having a neurological injury. |
| 09/06/1995 | EP0625153B1 Isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same |
| 09/06/1995 | EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions. |
| 09/06/1995 | EP0574416B1 Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them |
| 09/06/1995 | EP0559815B1 Optically active thiazoloisoindolinone derivatives with an antiviral action |
| 09/06/1995 | EP0555484B1 Water-soluble pentacyclic triterpene composition and production thereof |
| 09/06/1995 | EP0544899B1 Prostaglandins |
| 09/06/1995 | EP0509027B1 A process to correct and optimize the composition of a feed |
| 09/06/1995 | EP0478721B1 New benzocycloalkene carboxylic acid and process for producing it |
| 09/06/1995 | CN1108030A New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 09/06/1995 | CN1108029A Diamine salts of clavulanic acid |
| 09/06/1995 | CN1107888A Kelp sugar releasing enzyme, preparation and application of same |
| 09/06/1995 | CN1107850A Separation of cephalosporin isomers |
| 09/06/1995 | CN1107840A Substituted 1-oxo-1,2-dihydro-isochinolinoly-and 1,1-dioro-2H-1,2-benothiazinoylguanidine, preparation, application of same and pharmaceutical containing same |
| 09/06/1995 | CN1107839A Carbox amide |
| 09/06/1995 | CN1107835A A process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus |
| 09/06/1995 | CN1107708A Preparation of cream for treating chloasma |
| 09/06/1995 | CN1107707A Methods for inhibiting weight gain or inducing weight loss |
| 09/06/1995 | CN1107706A Methods of inhibiting seborrhea and acne |
| 09/06/1995 | CN1107705A Method for increasing libido in post-menopausal women |
| 09/06/1995 | CN1107704A Methods of inhibiting thrombin |
| 09/06/1995 | CN1107703A Methods of inhibiting hirsutism and alopecia in women |
| 09/06/1995 | CN1107702A Methods of inhibiting ovarian dysgenesis delayed puberty, or sexual infantilism |
| 09/06/1995 | CN1107701A Melatonin derivatives for use in treating sleep disorders |
| 09/06/1995 | CN1107700A Melatonin derivatives for use in terating desynchronization disorders |
| 09/06/1995 | CN1107699A Treatment of incontinence |
| 09/06/1995 | CN1107698A Broad-spectrum disinfectant liquor for external use and its preparation |
| 09/06/1995 | CN1029683C Process for preparing new steroids substituted at position 10 by a radical including a double or triple bond |
| 09/05/1995 | USH1487 Antitumor agents; treatment of ovarian, breast and other cancers |
| 09/05/1995 | US5447959 Vitamin A derivatives |
| 09/05/1995 | US5447958 Treatment of hypertension, congestive heart failure, angina pectoris, lower urinary tract dysfunction, prostatic hypertrophy |
| 09/05/1995 | US5447956 Treatment of leukemia with a imidazo carbamate |
| 09/05/1995 | US5447954 Antilipidemic agents |
| 09/05/1995 | US5447953 Biomasses to treat non-human animals |
| 09/05/1995 | US5447952 Treatment of anxiety with the aid of (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide |
| 09/05/1995 | US5447951 Use of 3-indolepyruvic acid or its salt |
| 09/05/1995 | US5447950 Anthra[1,9-c,d]pyrazol-6-(2H)-ones useful for treating anaerobic bacterial infections |
| 09/05/1995 | US5447948 Antipsychotic agents |
| 09/05/1995 | US5447947 Compositions and methods of treatment of sympathetically maintained pain |
| 09/05/1995 | US5447943 Novel benzopyran derivatives |
| 09/05/1995 | US5447942 Treatment of bronchoconstriction |
| 09/05/1995 | US5447941 Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes |
| 09/05/1995 | US5447940 Reinforced collagen matrix, dispersed antibiotic, analgesic, antiinflammatory, antiseptic |
| 09/05/1995 | US5447939 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
| 09/05/1995 | US5447937 CNS active tetrahydrobenzothienopyridines |
| 09/05/1995 | US5447936 Anticarcinogenic agents in dimethylacetamide solutions and carboxylic acids |
| 09/05/1995 | US5447934 Anti-allergic thiadiazolo [4,3-a]pyridine derivatives |
| 09/05/1995 | US5447931 New therapeutic use of heterocyclylpiperazines as 5-HT3 agonists and new compounds |
| 09/05/1995 | US5447930 Pramoxine hydrochloride and zinc acetate |
| 09/05/1995 | US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis |
| 09/05/1995 | US5447928 Antiischemic agents and nervous system disorders |
| 09/05/1995 | US5447926 Bactericides |
| 09/05/1995 | US5447925 Carbapenems with side-chain S; use to treat infections |
| 09/05/1995 | US5447924 Vitamin D analogues |
| 09/05/1995 | US5447923 Methods and compositions of diphenyl ether phosphate esters for the treatment of gastrointestinal disorders |
| 09/05/1995 | US5447922 α-phosphonosulfinic squalene synthetase inhibitors |
| 09/05/1995 | US5447919 Sulfated oligosaccharides |
| 09/05/1995 | US5447918 And antacid |
| 09/05/1995 | US5447917 D-tagatose as anti-hyperglycemic agent |
| 09/05/1995 | US5447912 Injecting the neuropeptides VIP and PHM and an adrenergic blocking agent |
| 09/05/1995 | US5447911 Antitumor agents |
| 09/05/1995 | US5447732 Polyglutamic acid and minerals |
| 09/05/1995 | US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals |
| 09/05/1995 | US5447726 Hydroxypropylmethylcellulose coating on anion exchange resin and silicon dioxide |
| 09/05/1995 | US5447719 β-glucuronidase inhibitor |
| 09/05/1995 | US5447716 Topical application as lotion, cream, milk, gel, microspheres, dispersion |
| 09/05/1995 | US5447712 Administering oxothazolidine carboxylate |
| 09/05/1995 | US5447011 Product with reduced H2 S content and a process of making the same |